Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. (Q35373645)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. |
scientific article |
Statements
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment (English)
D M Pickin
C J McCabe
L E Ramsay
N Payne
I U Haq
P R Jackson
1 September 1999
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference